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Introduction
The most critical modifiable risk factor for cancer is 
smoking, followed by weight, diet and physical activity 
(PA) [1]. Several biological mechanisms are involved in 
the preventive effects mediated by PA, involving not on-
ly reduction of the intra-abdominal fat store (a metaboli-
cally active site that releases carcinogens in overweight 
individuals) [2], but also the increase in anti-tumour 
immune defence [3] and reductions in the levels of in-
sulin and insulin-like growth factor-1 (IGF-1), mainly 
through the increased production of its binding protein 
(IGFBP-3). [4]. Unfortunately, the extreme variability 
of subjects included in trials and the heterogeneity in PA 
estimation make it difficult to establish the “highest” and 
“lowest” necessary levels, especially when we focus on 
specific target organs. The quantitative index used most 
commonly is the metabolic equivalent of task (MET), 
which expresses the energy cost as multiples of rest-
ing metabolic rate. Based on the MET concept, PA can 
be classified as either an occupational physical activity 
(OPA) or a leisure-time physical activity (LT-PA). We 
decided to analyse all presented data using the scheme 
proposed by the American College of Sports Medicine/
American Heart Association (ACSM/AHA) [5]:
•	 OPA:	low	for	sitting	work	(e.g.,	sitting	office	work,	
secretary), moderate for standing and walking 
work (e.g., store assistant, light industrial worker), 
heavy for manual work (e.g., forestry work, heavy 
farm work, heavy building and industrial work that 
lasted ≥ 20 minutes per day and caused increases in 
breathing, heart rate or sweating).
•	 LT-PA:	 low	 for	 <	 3	MET	 activities	 (e.g.,	 reading,	
watching television), moderate for 3–6 MET activi-
ties (e.g., walking, hunting, gardening more than 4 h/
week), heavy for > 6 MET activities (e.g., aerobics, 
jogging, running, skiing, swimming, bicycling more 
than 3 h/week or activities that lasted ≥ 20 minutes 
per day and caused increases in breathing, heart rate 
or sweating).
Even though there were several articles that contained 
questionnaires with more LT-PA/OPA categories, 
we decided to follow the aforementioned classifica-
tion scheme because more detailed subdivisions do not 
appear to improve meta-analysis–related interpreta-
tions [6]. It is also well established that approximately 
3 hours/week of heavy PA or 4 hours/week of moderate 
LT-PA are necessary to reduce the incidence of cancer 
among the middle-aged population [7].
The aim of this study is to provide an update on the ex-
perimental and epidemiological evidence for PA and the 
related reduction in cancer risk through the selection of 
articles that satisfy our quality assessment and selection 
criteria.
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Summary
Objective. The main aim of this paper is to review the evidence 
available from the date of PubMed’s inception to May 2011 for 
a link between cancer and physical activity (PA) in both animal 
models and humans.
Methods. We decided to select studies that comply with the 
scheme proposed by the American College of Sports Medicine/
American Heart Association (ACSM/AHA) that distinguish occu-
pational physical activity (OPA) and leisure-time physical activ-
ity (LT-PA), further classified in three levels of intensity (low, 
moderate and heavy) based on the Metabolic Equivalent of Task 
(MET) index.
Results. Considering animal models, there was strong evidence 
for an inverse association between voluntary wheel exercise and 
the risk of colon and breast cancer. Regarding human studies, 
we identified the following main results: 1) colorectum: LT-PA 
provided an overall colon risk reduction of 13-14%; 2) breast: 
significant reduction in the frequency of post-menopausal 
(PMP) cancers in women that practiced heavy and moderate 
LT-PA; 3) prostate: heavy OPA and LT-PA seemed to reduce 
the risk of advanced prostate cancers; 4) endometrium: strong 
protective effect of heavy/moderate LT-PA among overweight/
obese women; 5) lung: inverse relationship between heavy 
LT-PA and lung cancer in former or current smokers across all 
histologies.
Conclusion. Increased LT-PA is associated with cancer preven-
tion in several organs, but strong biases, such as body mass index 
(BMI), gender and age, make it difficult to assess which aspects 
of PA contribute most strongly to the reduced risk. Furthermore, 
we found few studies that indicated a protective role for OPA in 
cancer prevention when compared with LT-PA.
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Materials and methods
Study selection
We systematically searched PubMed (from the date of 
its inception to May 2011) for original articles, sys-
tematic reviews and meta-analyses about experimental 
studies on animal models and epidemiological studies 
in humans describing the association between PA and 
cancer incidence in the following organs: colorectum, 
breast, prostate, endometrium, lung, ovary, kidney, thy-
roid gland, testicle, and pancreas. We limited the search 
to publications in English. We used terms related to PA 
(‘physical activity’, ‘energy expenditure’ and ‘meta-
bolic equivalent’) and combined these with site-specific 
terms. We designed separate data extraction forms for 
case-control and cohort studies, and when data from a 
study was reported in more than one article, we included 
only the most recent publication.
From the results section of the selected articles, we ex-
tracted the reported relative risk (RR), odds ratio (OR) 
and 95% confidence limits (IC) for site-specific cancers 
in relation to PA exposure variables (total, occupational 
and leisure-time), gender difference and type of statisti-
cal data analysis performed. We considered an RR and 
an OR < 0.80 to indicate a significant risk reduction, a 
risk estimate between 0.80 and 1.25 to indicate no as-
sociation and a risk estimate higher than 1.25 to indicate 
an increased risk.
Data extraction and quality assessment
Because cancer is a multifactor outcome, we selected 
articles that adopted “exclusion criteria” regarding the 
main confounding biases (age, gender, cigarette smoke, 
alcohol consumption, BMI, daily diet) [8] and that used 
the aforementioned LT-PA/OPA categories.
Taking cues from similar reviews in the literature [2], we 
divided the epidemiological studies into six site-specific 
subgroups: colorectum, breast, prostate, endometrium, 
lung and others. Our methodology was similar to that 
used in the “World Cancer Research Fund (WCRF) first 
report” [9], which utilised four different and descending 
categories to indicate the strength of the effects of PA:
1. “convincing” (colorectum and breast);
2. “probable” (prostate);
3. “possible” (endometrium, lung);
4. “insufficient” (others).
Given the high level of heterogeneity in the study design, 
no attempt was made to estimate the overall quantitative 
synthesis of data across selected studies. We chose to 
present the meta-analysis data in Tables I and II.
Tab I. Colorectum.
Authors Year No. of 
studies
Type of analysis Site Type of 
exercise
Sex  RR  95%IC OR  95% IC
Samad et al. 2005  47 Fixed
meta-analisys
Colon
rectum
OpA
lt-pA
Any
m
F
m
F
m
F
0.79
1.11
0.78
0.71
1.00
1.00
(0.72-0.87)
(0.84-1.46)
(0.68-0.91)
(0.57-0.88)
(0.78-1.29)
(0.53-1.88)
0.70
0,49
0.58
0.61
0.94
0.87
(0.64-0.77)
(0.37-0.65)
(0.47-0.72)
(0.45-0.83)
(0.83-1.07)
(0.51-1.47)
Wolin et al.
Wolin et al.
2009
2011
 52
20
random
meta-analisys
random
meta-analisys
Colon
Colon 
OpA
lt-pA
Any
Any
Bg
Bg
m
F
m
F
0.85
0.82
0.81
0.89
0.81
0.87
(0.77-0.93)
(0.75-0.87)
(0.73-0.89)
(0.81-0.99)
(0.67-0.98)
(0.74-1.02)
0.73
0.69
0.68
0.72
-
-
(0.67-0.79)
(0.62-0.78)
(0.64-0.72)
(0.66-0.79)
harris et al. 2009 14 random
meta-analisys
Colon
rectum
lt-pA
lt-pA
m
F
m
F
0.80
0.86
1.02
1.29
(0.67-0.96)
(0.76-0.98)
(0.83-1.26)
(0.82-2.01)
-
-
-
-
Bg: both genders; OpA: occupational physical activity; lt-pA: leisure-time physical activity.
Tab II. Breast, endometrium and lung.
Authors Year No. of 
studies
Type of analysis Site Type of 
exercise
Sex  RR 95%IC OR 95% IC 
monnikhof 
et al.
2007 48 Arithmetic media 
of high quality 
studies (> 70%)
Breast tpA (Amp)
lt-pA (Amp)
tpA (pmp)
lt-pA (pmp)
F
F
F
F
 -
1.14
1.60
0.64
(0.36)*
(0.54)*
(0.33)*
0.94
0.42
-
0.71
(0.24)*
(0.26)*
(0.40)*
voskuil et al. 2005 11 Fixed meta-
analisys
endometrium Any F 0.77 (0.70-0.85) 0.71 (0.63-0.80)
tardon et al. 2007 13 random meta-
analisys
lung high pA
moderate/
mild pA
m
F
m
F
-
-
-
-
0.75
0.62
0.93
0.77
(0.66-0.86)
(0.48-0.79)
(0.85-1.00)
(0.66-0.89)
tpA: total physical activity, Amp: ante-menopause; pmp: post-menopause; * standard deviation.
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Results
Experimental studies on animal models
PA is defined as the full set of factors able to activate 
skeletal muscles and to involve energy consumption [10]. 
In such models, rodents run on wheels and treadmills 
so that the slope and velocity can be controlled in order 
to assure that all animals experience the same amount 
of PA. Voluntary wheel exercise must be preferred to 
forced treadmill exercise because the latter, in nocturnal 
animals such as rats and mice, causes sleep deprivation, 
which is known to be stressful [11], and stress plays a 
major role in the initiation and progression of cancers 
through oxidative stress and DNA damage (especially 
in the colorectum) [12]. The main confounder was “food 
intake” because administration of a high-fat diet [13] or 
regulated energy intake [14] influenced both the inci-
dence and the anatomical distribution of tumours.
Colorectum
Basterfield et al. [13] collected eight studies that induced 
cancer through the administration of colic carcinogens 
(azoxymethane and 1,2-dimethylhydrazine) in male 
Fisher and Sprague-Dawley rats or by genetic muta-
tions of the Apc gene (the gatekeeper gene for bowel 
cancer) in monitored mice to induce spontaneous intesti-
nal neoplasms. Rats benefited more from PA than mice; 
a possible explanation is not only the different primary 
endpoints (colon cancer for rats versus bowel adenomas 
for mice) but also the different behavioural responses to 
the exercise intervention. In particular, mice spontane-
ously reduced non-exercise physical activity (NEPA) 
so that they maintained a similar energy balance despite 
their greater energy expenditure during daily forced run-
ning [13].
Moreover, the original articles underlined the synergis-
tic effect of PA when administered in combination with 
a high concentration of colonic butyrate and increased 
sleep duration [15] as well as the inverse correlation 
between daily wheel running distance and total polyp 
number [16]. Baltgalvis et al. found that treadmill exer-
cise decreased the number of macrophages and down-
regulated pre-carcinogenic markers in intestinal polyps 
(e.g., ↓ TUNEL positive cells, ↓ bax protein expression, 
↑ catenin phosphorylation) [17].
Breast
Three articles reported that wheel exercise reduced both 
the incidence and multiplicity of breast cancer in 1-me-
thyl-nitrosourea-treated mice through the reduction of 
proteins involved in cell proliferation (e.g., cyclin D1), 
the elevation of those involved in apoptosis via the mito-
chondrial pathway (e.g., caspase-3 activity) [14, 18] and 
blood marker variations (i.e., ↑ plasma corticosterone, 
↓ IGF-1, ↓ insulin, ↓ leptin) [19]. The involvement of 
citrate synthase is controversial because free-wheel run-
ning increased the level of enzyme activity and reduced 
the average number of cancers per rat, but regression 
analyses failed to provide evidence of a significant as-
sociation [20].
Other sites
Esser et al. [21] found that exercise decreased prostate 
cancer progression in predisposed transgenic C3Tag 
mice, while Michna et al. [22] determined that running 
wheel exercise decreased the number and size of non-
malignant tumours and squamous cell carcinomas of the 
skin in UVB-induced carcinogenesis.
Epidemiological studies
Colorectum
For the colorectum, we selected four meta-analyses [6, 23-
25] and three original articles [26-28]. No association was 
consistently found for LT-PA and rectal cancer [6, 23]; 
the consensus is that one is unlikely to exist [24]. LT-PA 
provides a colon cancer risk reduction of 13% and 14% 
from the 20th to 95th percentile for men and women, 
respectively [6]. One recent meta-analysis found a de-
creased risk, especially for large/advanced polyps [25]. 
The magnitude of risk reduction reported in case-control 
studies was stronger than reported in cohort studies; this 
difference may be explained by greater recall biases and 
a stronger PA assessment in case-control studies [24] 
(Tab. I). The PA effect was independent of other factors; 
there was no statistical alteration after adjustment for con-
founders such as BMI, smoking and alcohol. Moreover, 
recent studies showed that PA also influenced mortality 
in patients diagnosed with colon cancer [26].
In terms of biological patterns, several mechanisms 
and response pathways have been hypothesised to 
explain the protective effect of PA. The mechanisms 
supported by the strongest evidence involve a lower 
faecal bile acid concentration [27], increased gas-
trointestinal transit [28], decreased levels of insulin 
and IGF-1, and a decreased IGF-1:IGF-BP3 (binding 
protein 3) ratio [24]. The latter is the most probable 
because hyperinsulinemia and insulin resistance pro-
vide a unifying mechanism through which PA, die-
tary and other lifestyle factors have a causal effect on 
colorectal cancer.
Breast
For the breast, we selected one meta-analysis [29], 
three reviews [30-32] and three original articles [33-
35]. The lack of a consistent PA versus breast cancer 
association is mainly due to population heterogeneity 
because breast cancer is influenced by non-modifiable 
factors such as early age at menarche, nulliparity, older 
age at first childbirth and menopause. For that reason, 
Monninkhof et al. [29] presented a quality scoring sys-
tem of selected studies without a random or fixed meta-
analysis calculation. According to our review design, 
we calculated the OR and RR arithmetic mean of high-
quality studies (> 70%) [29]. We found a significant 
reduction of post-menopausal (PMP) cancers in wom-
en that practiced LT-PA (Tab. II). Among post-meno-
pausal women, the breast seemed to be more sensitive 
to reductions in BMI and oestrogen levels induced by 
LT-PA [30, 31].
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Regarding hormone receptor status, Adams et al. reported 
a protective effect mediated by LT-PA in both receptor(+) 
and receptor(-) cancers. In particular, premenopausal 
women who reported LT-PA during both adolescence and 
the last 10 years showed a significant decrease in the risk 
for receptor(+) and receptor(-) cancer (decreases of 66% 
and 49%, respectively) [33]. In addition, West-Wright 
et al. demonstrated that women with heavy or moderate 
levels of LT-PA had lower risk, regardless of hormone 
receptor status, but this applied only to overweight wom-
en [34]. In conclusion, the idea that LT-PA is associated 
with a decreased risk of breast cancer, partly through the 
activation of hormone-related mechanisms, is controver-
sial because complete information regarding receptor sta-
tus is not always available for the studied subjects [35], 
and we know little about the differential response of oes-
trogenic and progesteronic receptors [32].
Moreover, BMI level did not appear to exert a dramat-
ic influence on the preventive effect mediated by LT-
PA [29], even if the greatest benefits were observed 
among lean women with a BMI < 22 [32]. This result 
is easily explicable if we consider that adipose tissue is 
the major source of endogenous oestrogen, especially in 
post-menopausal women [32].
Prostate
For the prostate, we selected one review [36] and eight 
original articles [37-44]. The lack of meta-analyses is 
due to strong confounders such as large geographical 
variations in incidence, end-point choice (localised or 
advanced cancers) and PA type. In addition, early detec-
tion remains of uncertain benefit, and controversy exists 
regarding the most appropriate treatment for early-stage 
prostate cancer [36]. Heavy OPA seemed to reduce the 
risk of advanced prostate cancers [37]. Subjects with 
moderate OPA (standing and walking work) experi-
enced a 20% lower risk than those with low OPA (sitting 
work), and heavy LT-PA (bicycling) decreased the risk 
of all types of prostate cancer (especially advanced cas-
es) [38]. Moreover, moderate LT-PA minimised the side 
effects related to androgen deprivation therapy (ADT) in 
prostate cancer patients [39, 40], and all levels of LT-PA 
reduced the risk of aggressive prostate cancers [41] and 
benign prostatic hyperplasia (BPH) [42].
PA could reduce the incidence of prostate cancer by low-
ering basal testosterone levels, suppressing 5-α reductase 
activity, improving immune system function (e.g., the 
number and capacity of NK cells) and enhancing antioxi-
dant activity (e.g., scavenger enzymes such as superox-
ide dismutase and glutathione peroxidase and levels of 
antioxidants such as glutathione and tocopherols) [36]. 
Moreover, PA increased the cellular p53 protein content, 
leading to reduced p21-mediated cellular growth, the 
induction of apoptosis through the mitochondrial path-
way [43], and a reduced IGFI:IGFBP3 ratio (a high ratio 
was associated with increased BPH risk) [44].
Endometrium
For the endometrium, we selected one meta-analy-
sis [45], one review [46] and five original articles [47-
51]. Voskuil et al. [45] highlighted the confounding 
effect of BMI, which nonetheless appeared to be an in-
dependent factor, because the incidence was decreased 
in both normal-weight and obese women (Tab. II). In 
contrast with Voskuil et al., recent cohorts displayed 
stronger effects of heavy [46] and moderate [47] LT-
PA among overweight/obese women and no correlation 
with OPA [46]. However, Conroy et al. pointed out that 
overweight women (BMI ≥ 25) have a higher endome-
trial cancer risk, regardless of LT-PA level [48]; it there-
fore remains difficult to assess the influence of BMI 
versus LT-PA. Moreover, recent case-control studies 
underlined the importance of distinguishing OPA from 
LT-PA to fully understand the effect of PA [49], in par-
ticular the protective effect of heavy LT-PA, especially 
between menarche and full-term pregnancy and after 
menopause [50].
Cust et al. [51] summarised the biological mechanisms 
hypothesised to underlie the LT-PA–mediated improve-
ment in insulin sensitivity, the increase in the levels of 
sex hormone-binding globulin (SHBG) and IGFBP-1, 
and the influence on the balance of oestrogen and pro-
gesterone levels. The ‘unopposed oestrogen hypothesis’ 
states that prolonged exposure to oestrogen, insuffi-
ciently counterbalanced by progesterone, is a major ae-
tiologic determinant of endometrial cancer. LT-PA was 
associated with menstrual cycle irregularities, which de-
crease the cumulative number of ovulatory cycles and 
reduce exposure to oestrogens [51].
Lung
For the lung, we selected one meta-analysis [52] and 
five original articles [53-57]. Tardon et al. [52] in-
cluded only trials that provided a smoking adjustment. 
They found a greater reduction for heavy LT-PA than 
for moderate LT-PA (Tab. II), with a significant dose-
response relationship. Recent studies have shown quite 
similar LT-PA effects across all histologies in former 
or current smokers, but only effects unrelated to LT-PA 
among those who have never smoked [53], a stronger 
effect of LT-PA on major cell cancer [54], as well as 
a synergistic effect of LT-PA and diet on lung cancer 
in smokers [55]. In contrast, Staindorf et al. found an 
augmented lung cancer risk for moderate OPA and un-
employed men, but these data were probably influenced 
by occupational exposures [56].
The IGFI:IGFBP3 ratio seems to be a crucial part of 
the mechanism underlying the protective effect of LT-
PA [57]. In particular, high levels of circulating IGF-1 
were associated with an increased risk of lung cancer, 
while high levels of IGFBP-3 were associated with a 
decreased risk [57]. However, it is difficult to assess 
all the effects of PA because the lung is affected by 
several independent confounders (smoke, air pollution 
and food intake) that influence both histology and gen-
der differences in incidence [52]. The effect of smok-
ing could be investigated using cohorts of individuals 
that have never smoked as controls. However, the low 
rates of lung cancer in this population make such stud-
ies difficult.
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Other sites
•	 Ovary:	Although	Olsen	et	al.	found	a	modest	inverse	
association between the level of LT-PA and the risk 
of ovarian cancer [58], Rossini et al. [59] showed a 
stronger reduction in the risk of invasive epithelial 
ovarian cancer in subjects that practice heavy LT-PA 
compared with those that practice moderate LT-PA.
•	 Kidney:	 one	 review	 [60]	 underlined	 that	 moder-
ate LT-PA during adolescence and heavy LT-PA 
in adults could protect against renal cell carcinoma 
through a reduction in body weight, blood pressure, 
chronic inflammation, oxidative stress and an im-
provement of insulin sensitivity.
•	 Thyroid	gland: one original article [61] provided a 
possible inverse relation between papillary thyroid 
cancer incidence and heavy LT-PA during the two 
years before diagnosis with cancer.
•	 Testicle	and	pancreas:	no	studies	predicted	a	preven-
tive effect mediated by PA.
Discussion
The effect of PA on cancer incidence is perceived to 
be large, but quantification measures and the implied 
biological mechanisms remain elusive. A possible dose-
response pattern [23, 52] compelled the “World Cancer 
Research Fund (WRCF) second report” [62] to report 
“more PA is better”, but drove researchers to three unex-
plained questions: how much PA is enough, what type is 
best (LT-PA versus OPA) and when during the life cycle 
is it important? It is possible that PA non-standardised 
available measures contributed to inconsistency in some 
results. Hence, we mainly focused on meta-analysis re-
ports because their selection criteria allow one to exclude 
major heterogeneities that cannot be controlled in single 
trials. However, few studies found a protective role for 
OPA compared with LT-PA in cancer prevention and 
the explanation could be that occupational activities are 
known to be stressful and stress can partially counteract 
the beneficial effect of OPA through oxidative stress and 
DNA damage [12].
In order to remove all confounding factors and the prom-
inent role played by genetic predisposition, cancer out-
comes may not represent primary end points. There is a 
need for more “intermediate end-points” to assess PA 
biological effects through the measure of pre-carcino-
genic biomarkers (e.g., apoptosis-related proteins, IGFs 
and immune markers) so that they can be introduced in 
community intervention studies [62, 63].
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